Volume | 233,360 |
|
|||||
News | - | ||||||
Day High | 11.69 | Low High |
|||||
Day Low | 10.27 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Nevro Corp | NVRO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
11.56 | 10.27 | 11.69 | 11.53 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3,802 | 233,360 | $ 10.89 | $ 2,540,739 | - | 10.265 - 28.89 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:55:29 | 114 | $ 10.28 | USD |
Nevro Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
385.45M | 36.40M | - | 425.17M | -92.21M | -2.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Nevro News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVRO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 10.60 | 11.79 | 10.265 | 10.75 | 883,275 | -0.32 | -3.02% |
1 Month | 13.05 | 13.42 | 10.265 | 11.61 | 547,782 | -2.77 | -21.23% |
3 Months | 16.83 | 17.625 | 10.265 | 13.53 | 501,614 | -6.55 | -38.92% |
6 Months | 16.57 | 22.64 | 10.265 | 16.39 | 525,579 | -6.29 | -37.96% |
1 Year | 26.91 | 28.89 | 10.265 | 19.07 | 538,465 | -16.63 | -61.80% |
3 Years | 155.18 | 182.45 | 10.265 | 53.40 | 548,935 | -144.90 | -93.38% |
5 Years | 60.69 | 188.14 | 10.265 | 75.21 | 491,880 | -50.41 | -83.06% |
Nevro Description
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. |